RPRX vs VICI · P/E 15, rev $1.30B vs P/E 9.3, rev $2.08B
Royalty Pharma Plc (RPRX) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
RPRX currently screens at market cap $20.45B and trailing P/E 14.8. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the RPRX and VICI stock pages for the full models.
Not investment advice.